| Product Code: ETC10602415 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The import shipments of human papilloma virus vaccines to Israel in 2024 were predominantly sourced from Switzerland, USA, Germany, China, and Belgium, showcasing a diverse supplier base. Despite a negative Compound Annual Growth Rate (CAGR) from 2020 to 2024, there was a notable growth rate of 8.63% from 2023 to 2024. The Herfindahl-Hirschman Index (HHI) indicated a sustained high concentration within the market in 2024, highlighting the competitive dynamics among the key exporting countries.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Human Papilloma Virus Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Human Papilloma Virus Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Human Papilloma Virus Market - Industry Life Cycle |
3.4 Israel Human Papilloma Virus Market - Porter's Five Forces |
3.5 Israel Human Papilloma Virus Market Revenues & Volume Share, By Virus Type, 2021 & 2031F |
3.6 Israel Human Papilloma Virus Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Israel Human Papilloma Virus Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.8 Israel Human Papilloma Virus Market Revenues & Volume Share, By Target Population, 2021 & 2031F |
3.9 Israel Human Papilloma Virus Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Israel Human Papilloma Virus Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of HPV vaccination in Israel |
4.2.2 Rising incidence of HPV-related cancers in the country |
4.2.3 Government initiatives and programs promoting HPV vaccination |
4.3 Market Restraints |
4.3.1 High cost of HPV vaccines and testing services |
4.3.2 Limited access to healthcare services in certain regions of Israel |
4.3.3 Cultural or religious beliefs impacting the acceptance of HPV vaccination |
5 Israel Human Papilloma Virus Market Trends |
6 Israel Human Papilloma Virus Market, By Types |
6.1 Israel Human Papilloma Virus Market, By Virus Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Human Papilloma Virus Market Revenues & Volume, By Virus Type, 2021 - 2031F |
6.1.3 Israel Human Papilloma Virus Market Revenues & Volume, By HPV 16 & 18, 2021 - 2031F |
6.1.4 Israel Human Papilloma Virus Market Revenues & Volume, By Low-Risk HPV Strains, 2021 - 2031F |
6.2 Israel Human Papilloma Virus Market, By Vaccine Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Human Papilloma Virus Market Revenues & Volume, By Preventative Vaccine, 2021 - 2031F |
6.2.3 Israel Human Papilloma Virus Market Revenues & Volume, By Therapeutic Vaccine, 2021 - 2031F |
6.3 Israel Human Papilloma Virus Market, By Application Area |
6.3.1 Overview and Analysis |
6.3.2 Israel Human Papilloma Virus Market Revenues & Volume, By Preventative Vaccination, 2021 - 2031F |
6.3.3 Israel Human Papilloma Virus Market Revenues & Volume, By Cancer Prevention, 2021 - 2031F |
6.4 Israel Human Papilloma Virus Market, By Target Population |
6.4.1 Overview and Analysis |
6.4.2 Israel Human Papilloma Virus Market Revenues & Volume, By Teenagers, Young Adults, 2021 - 2031F |
6.4.3 Israel Human Papilloma Virus Market Revenues & Volume, By High-Risk Individuals, 2021 - 2031F |
6.5 Israel Human Papilloma Virus Market, By End Use |
6.5.1 Overview and Analysis |
6.5.2 Israel Human Papilloma Virus Market Revenues & Volume, By Cervical Cancer Prevention, 2021 - 2031F |
6.5.3 Israel Human Papilloma Virus Market Revenues & Volume, By Oncology Care, 2021 - 2031F |
7 Israel Human Papilloma Virus Market Import-Export Trade Statistics |
7.1 Israel Human Papilloma Virus Market Export to Major Countries |
7.2 Israel Human Papilloma Virus Market Imports from Major Countries |
8 Israel Human Papilloma Virus Market Key Performance Indicators |
8.1 Rate of HPV vaccination coverage among the target population |
8.2 Number of HPV-related cancer cases diagnosed annually |
8.3 Percentage of healthcare facilities offering HPV vaccination services |
8.4 Public perception and acceptance of HPV vaccination through surveys or polls |
8.5 Investment in research and development for new HPV vaccines and treatments |
9 Israel Human Papilloma Virus Market - Opportunity Assessment |
9.1 Israel Human Papilloma Virus Market Opportunity Assessment, By Virus Type, 2021 & 2031F |
9.2 Israel Human Papilloma Virus Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.3 Israel Human Papilloma Virus Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.4 Israel Human Papilloma Virus Market Opportunity Assessment, By Target Population, 2021 & 2031F |
9.5 Israel Human Papilloma Virus Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Israel Human Papilloma Virus Market - Competitive Landscape |
10.1 Israel Human Papilloma Virus Market Revenue Share, By Companies, 2024 |
10.2 Israel Human Papilloma Virus Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |